Antibody against Interferon-α 2b in Serum of the Patients with Chronic Hepatitis C and its Clinical Significance: A Clinical Trial
| Author | wangjian wangjian | en |
| Author | Wang Pingping | en |
| Author | Xiang Guiju | en |
| Author | wangjian wangjian | en |
| Author | Wang Pingping | en |
| Author | Xiang Guiju | en |
| Issued Date | 2009-06-30 | en |
| Abstract | suppresses HCV replication are not well-known; only limited benefits are achieved with the therapy because the virus in turn, directs some mechanisms to resist the host IFN-α response. The present study was undertaken to determine the therapeutic effects of IFN-α 2b and to measure the serum level of antibody against IFN-α 2b (anti-IFN-α 2b) after treatment with IFN-α 2b in patients with chronic hepatitis C. | en |
| DOI | https://doi.org/ | en |
| Keyword | Interferon-α 2b | en |
| Keyword | Anti-IFN-α 2b | en |
| Keyword | Hepatitis C | en |
| Keyword | Treatment | en |
| Publisher | Brieflands | en |
| Title | Antibody against Interferon-α 2b in Serum of the Patients with Chronic Hepatitis C and its Clinical Significance: A Clinical Trial | en |
| Type | Research Article | en |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- 111320090202.pdf
- Size:
- 131.54 KB
- Format:
- Adobe Portable Document Format
- Description:
- Article/s PDF